Abstract 6485: Combination of the GCN2 activator HC-7366 with VEGFR-TKI results in greater efficacy than VEGFR-TKI alone or VEGFR-TKI/HIF-2i combinations in ccRCC
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Weiyu Zhang, Kathryn Bieging-Rolett, Ashley LaCayo, Ben Harrison, Jeremy Drees, Crissy Dudgeon, Nandita Bose, Eric S. Lightcap
Institution: HiberCell, Inc. (United States)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148859643
Cites:
Cited by:
Related to: